Hazelden Betty Ford Foundation
-
Services:
- Group counseling
- Individual counseling
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- Smoking/vaping/tobacco cessation counseling
- Hepatitis education, counseling, or support
- HIV or AIDS education, counseling, or support
- Sign language services for the deaf and hard of hearing
- Smoking permitted in designated area
- Nicotine replacement
- Buprenorphine without naloxone
- Non-nicotine smoking/tobacco cessation
- Acamprosate (Campral®)
- Disulfiram
- Medication for mental disorders
- Naltrexone (extended-release, injectable)
- Buprenorphine with naloxone
- Naltrexone (oral)
- Clonidine
- Buprenorphine (extended-release, injectable)
- Drug or alcohol urine screening
- Testing for Hepatitis B (HBV)
- TB screening
- Testing for Hepatitis C (HCV)
- HIV testing
- STD testing
- Breathalyzer or blood alcohol testing
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Substance use treatment
- Detoxification
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Clients with co-occurring pain and substance use disorders
- Clients who have experienced trauma
- Adult women
- Clients with co-occurring mental and substance use disorders
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Adult men
- Short-term residential
- Outpatient day treatment or partial hospitalization
- Residential/24-hour residential
- Outpatient
- Residential detoxification
- Trauma-related counseling
- 12-step facilitation
- Cognitive behavioral therapy
- Brief intervention
- Motivational interviewing
- Substance use disorder counseling
- Relapse prevention
- Contingency management/motivational incentives
- The Joint Commission
- State department of health
- Benzodiazepines Detoxification
- Alcohol Detoxification
- Cocaine Detoxification
- Opioids detoxification
- Methamphetamines detoxification
- Medication routinely used during detoxification
- Outcome follow-up after discharge
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
- Private non-profit organization
- Vaping not permitted
- Housing services
- Mentoring/peer support
- Self-help groups
- Recovery coach
- Early intervention for HIV
- Case management service
- Mental health services
- Suicide prevention services
- Social skills development
- Maintenance service with medically supervised withdrawal after stabilization
- Lofexidine or Clonidine detoxification
- Prescribes buprenorphine
- Relapse prevention with naltrexone
- Buprenorphine maintenance
- Buprenorphine detoxification
- Prescribes naltrexone
- Adults
- Young Adults
- Male
- Female
- Screening for mental disorders
- Screening for tobacco use
- Outreach to persons in the community
- Comprehensive substance use assessment
- Complete medical history/physical exam
- Comprehensive mental health assessment
- Screening for substance use
- No formal relationship with prescribing entity
- Private health insurance
- SAMHSA funding/block grants
- Federal military insurance (e.g., TRICARE)
- Cash or self-payment
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
Education and Counseling Services
Language Services
Facility Smoking Policy
Pharmacotherapies
Testing
Type of Alcohol Use Disorder Treatment
Type of Care
Special Programs/Groups Offered
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Treatment Approaches
License/Certification/Accreditation
Detoxification (medical withdrawal) Services
Transitional Services
Facility Operation (e.g., Private, Public)
Facility Vaping Policy
Recovery Support Services
Ancillary Services
Type of Opioid Treatment
Age Groups Accepted
Gender Accepted
Assessment/Pre-treatment
External Source of Medications Used for Alcohol Use Disorder Treatment
Payment/Insurance/Funding Accepted
Opioid Medications used in Treatment